Dr. Richard Nash @ColoradoBlood@twitter.com @CBCIDocs@twitter.com is giving @CUHematology@twitter.com grand rounds this afternoon on the role of transplantation in severe autoimmune diseases. ๐งต #bmtsm #celltherapy
RT @AndreaAnampaG@twitter.com
Our work on the Health Disparities Experienced by Hispanic Americans with Multiple Myeloma is now at Clinical Hematology International. Thanks to
@Sarasinh@twitter.com, @inas_md@twitter.com and @HadidiSamer@twitter.com
LINK: https://link.springer.com/article/10.1007/s44228-022-00026-2
#HOFellows #Latinx #MMsm #BMTsm #myeloma #GlobOnc #MedTwitter
๐ฆ๐: https://twitter.com/AndreaAnampaG/status/1609926850389622784
#hofellows #latinx #MMSM #bmtsm #myeloma #globonc #medtwitter
For all you PCNSL #lymsm nerds out there: check out those PFS and OS curves! Elegant study; ASCT is the better option for consolidation over non-myeloablative chemotherapy. #ASH22 #bmtsm
RT @majorajay@twitter.com
ASCT had superior PFS and OS (!!!) than R-DeVIC consolidation. Confirms what we have suspected. PROs were collected and eager to looking at those in the ASCT arm as well. #ASH22 #lymsm #bmtsm
2/2
RT @doctorpemm@twitter.com
#ASH22 | @gotoPER@twitter.com @ASH_hematology@twitter.com ASH Friday Satellite Symposium ๐๐๐Dr Q giving an awesome ๐๐ฝ talk on Future Directions in #BPDCN !!!! ๐ฅ ๐๐ฝ @ninashah33@twitter.com @DrKrinaPatel@twitter.com @mtmdphd@twitter.com @szusmani@twitter.com @MediHumdani@twitter.com @NitinJainMD@twitter.com @lane_andy@twitter.com @DrMonicaGuzman@twitter.com #leusm #mmsm #bmtsm
๐ฆ๐: https://twitter.com/doctorpemm/status/1601342924712968193
#ash22 #bpdcn #leusm #mmsm #bmtsm
RT @GomezDLeonMD@twitter.com
Grandchildren haplo donors in Hopkins cohort (n=29) no difference in NRM with propensity score, similar OS and PFS.
Aljawai #ASH22 #BMTsm
https://ash.confex.com/ash/2022/webprogram/Paper169028.html
๐ฆ๐: https://twitter.com/GomezDLeonMD/status/1601665050787225600
RT @DrMiguelPerales@twitter.com
Adding Itacitinib to Conventional GVHD Prophylaxis #ASH22 #bmtsm https://www.docwirenews.com/conference-coverage/ash-gvhd/adding-itacitinib-to-conventional-gvhd-prophylaxis/?utm_source=twittershare&utm_medium=socialmedia&utm_campaign=social_media_track via @mydocwire@twitter.com
๐ฆ๐: https://twitter.com/DrMiguelPerales/status/1601369942388928512
RT @doctorpemm@twitter.com
#ASH22 Awesome ๐๐ฝ talk by Dr @Transplant_Doc@twitter.com at our #BPDCN @ASH_hematology@twitter.com Friday Satellite Symposium !!! #leusm #bmtsm @MediHumdani@twitter.com @BldCancerDoc@twitter.com @lane_andy@twitter.com @DrMonicaGuzman@twitter.com @Lymphoma_Doc@twitter.com @DrKrinaPatel@twitter.com @ninashah33@twitter.com
๐ฆ๐: https://twitter.com/doctorpemm/status/1601350088386785281
#safety #celltherapy #celltherapies #immunotherapy #genetherapy #cellulartherapeutics #IO #cancer #oncology #dlbcl #lymphoma #cartecells #cartcellrx #nkcells #nkcars #bispecifics #tcellengagers #bloodcancers #lymphoma #multiplemyeloma #solidtumors #Breastcancer #GIcancer #cartcell #cartcells #cartcellrx #msc #mesenchymalstemcells #mesenchymalstemcell #CRISPR #crisprcas9 #genetherapy #geneediting #checkpointinhibitors #bmt #bmtrx #bmtsm #tcellrx
#safety #CellTherapy #celltherapies #Immunotherapy #genetherapy #cellulartherapeutics #IO #cancer #oncology #dlbcl #lymphoma #cartecells #cartcellrx #NKcells #nkcars #bispecifics #tcellengagers #BloodCancers #MultipleMyeloma #solidtumors #breastcancer #gicancer #CARTCell #CARTCells #msc #mesenchymalstemcells #mesenchymalstemcell #crispr #crisprcas9 #geneediting #checkpointinhibitors #BMT #bmtrx #bmtsm #tcellrx
RT @doctorpemm@twitter.com
#ASH22 | Looking forward to seeing all of you at @ASH_hematology@twitter.com in #NOLA next week ! Please follow me for all of the latest updates from #ASH22 | Make sure you take a moment to download the #ASH22 app ๐ it is very helpful ! #MPNSM #BPDCN #leusm #bmtsm #ImmunoOnc #meded ๐๐พ
๐ฆ๐: https://twitter.com/doctorpemm/status/1599052051798839301
#ash22 #nola #mpnsm #bpdcn #leusm #bmtsm #Immunoonc #MedEd